THE USE OF HORMONES DURING THE PERIMENOPAUSAL PERIOD IN SLOVENIA
Abstract
Background. We want to collect data on the use of hormone therapy (HT) in perimenopausal women in Slovenia. These data were to serve as the basis for evaluation of the most frequently prescribed HT, and of the distribution of prescriptions by Slovene health regions. Consequently, the percent of women aged 40–65 years, current hormone replacement therapy (HRT) users was to be assessed.
Methods. The analysis was made on the basis of the data collected by the automatic processing of prescriptions (AOR). Reliability of the data has been excellent since the introduction of the health insurance card. The data on drug use are expressed as defined daily doses (DDD) per 1000 inhabitants aged 40–65 years. The information on the number of women in a certain age group and their number in a certain medical region was obtained from the Statistical Institute of Slovenia and from the database of the Institute of Health Insurance of Slovenia. DDD is a technical unit, by means of which drug use can be compared. DDD is a mean daily dose of the drug prescribed for the main indication in adults, the unit being 1 gram of the active substance. The AOR data have become reliable after 2001, therefore our analysis comparised the years 2001 and 2002. Comparison of the data was done using the list of drugs prepared according to the Anatomical Therapeutic Chemical classification (ATC) for coding drugs.
Results. HRT (at least one pack) was found to be used by 12.5% of women in 2001 and 12.4% in 2002. The estimated percent of women receiving HRT for at least 6 months was 6.5% in 2001 and 6.4% in 2002. Considering DDD, most frequently prescribed drugs were estrogens and monophasic estrogens + progesterone, these in the age groups 45–55 years; beyond this age HT was used decreasingly. Conjugated equine estrogen and antiandrogens combined with estrogens were prescribed the least. By medical regions, most systemic hormones were prescribed in the Ljubljana and Novo mesto regions, and least in the Murska Sobota and Krško regions. Local estrogens were most frequently prescribed in the Murska Sobota, Nova Gorica and Koper regions, and least frequently in the Krško region. The HRT prescription rate showed a 5–19% decrease in 2002 compared to 2001.
Conclusions. Although by the prescribed DDD of HRT Slovenia is comparable to Denmark, HT is not being used continuously by sufficient percent of women (6.5%). Therefore it is mandatory, especially for stricter indications for HRT, to provide better education to professionals, who are to properly advise Slovene women on how and when to decide on HRT use.
Downloads
References
Birkhauser MH. Definitions and epidemiology In: Scientific Material 1st Postgraduate Academic Course on Menopause, Toledo, Spain, November 7–11 2001 Toledo: ACH, 2001: 1–11.
Houck JA. »What do these women want?«: Feminist responses ro feminine forever, 1963–1980. Bull Hist Med 2003; 77: 103–32.
Lemay A. The relevance of the Women’s Health Initiative results on combined hormone replacement therapy in clinical practice. J Obstet Gynaecol Can 2002; 24: 683–8.
Grimes DA, Lobo RA. Perspectives on the Women’s Health Initiative trial of hormone replacement therapy. Obstet Gynaecol 2002; 100: 1344–53.
Flystra DL. Postmenopausal hormone therapy: have HERS II and WHI given any new information? J S C Med Assoc 2002; 98: 299–304.
Neves-e-Castro M, Samsioe G, Doren M, Skouby SO. Results from WHI and HERS II – Implications for women and prescriber of HRT. 2002; Maturitas 42: 255–8.
Franić D. Compliance in nadomestno hormonsko zdravljenje. In: Zbornik I slovensko-hrvatski simpozij o sodobnih pogledih na menopavzo in andropavzo, Atomske Toplice, 5.–7. 4. Atomske Toplice: Slovensko zdravniško društvo, 2001: 85–90.
Ravnikar V. Barriers for taking long-term hormone replacement therapy: Why do women not comply with therapy? In: Proceedings Novo Nordisk Women’s Healthcare Symposium. Barcelona; September 13, 1996. Barcelona: Novo Nordisk, 1996.
Anon. Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDD’s) 2002. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2002: 35–7.
Anon. Guidelines for ATC classification and DDD assignment. 5th edition. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2001: 20–21.
Pečar-Čad S, Rupnik-Ravnihar I, Ambulantno predpisovanje zdravil v Sloveniji po ATC klasifikaciji v l. 2001. Zdrav var 2002; 41: Suppl. 7: 46.
Ferguson DJ, Anderson TJ. Morphological evaluation of cell turnover in relation to menstrual cycle in the »resting« human breast. Br J Cancer 1988; 44: 177181.
Going JJ, Anderson TJ, Battersby S et al. Proliferative and secretory activity in human breast during natural and arteficial menstrual cycle. Am J Pathol 1988; 130: 193–204.
Nachtigall LE, Raju U Bannerjee S et al. Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies:association with sex hormone-binding globulin, estradiol and estrone levels. Menopause 2000; 7: 243–50.
Lukanovič A. Uroginekološko staranje. In: Zbornik I slovensko-hrvatski simpozij o sodobnih pogledih na menopavzo in andropavzo, Atomske Toplice, 5.–7. 4.; 2001: 83–5.
Samsioe G. The Gynourinary system. In: Lobo RA, Klesey J, Marcus R. Menopause (Biology and Pathobiology) Academic Press, San Diego California 2000; 22: 327–38.
Notelovitz M. The clinical practice impact of the Women’s Health Initiative: political vs biologic correctness. Maturitas 44 (2003): 3–9.
Graser T, Koytchev R, Romer T et al. Dienogest as a progestin for hormone replacement therapy. Drug of Today 1999; 35 Suppl. C: 115–26.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
